A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways

Tianzhi Huang, Angel A. Alvarez, Rajendra P. Pangeni, Craig M. Horbinski, Songjian Lu, Sung Hak Kim, C. David James, Jeffery J. Raizer, John A. Kessler, Cameron W. Brenann, Erik P. Sulman, Gaetano Finocchiaro, Ming Tan, Ryo Nishikawa, Xinghua Lu, Ichiro Nakano, Bo Hu*, Shi Yuan Cheng

*Corresponding author for this work

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Molecularly defined subclassification is associated with phenotypic malignancy of glioblastoma (GBM). However, current understanding of the molecular basis of subclass conversion that is often involved in GBM recurrence remain rudimentary at best. Here we report that canonical Wnt signalling that is active in proneural (PN) but inactive in mesenchymal (MES) GBM, along with miR-125b and miR-20b that are expressed at high levels in PN compared with MES GBM, comprise a regulatory circuit involving TCF4-miR-125b/miR-20b-FZD6. FZD6 acts as a negative regulator of this circuit by activating CaMKII-TAK1-NLK signalling, which, in turn, attenuates Wnt pathway activity while promoting STAT3 and NF-κ B signalling that are important regulators of the MES-associated phenotype. These findings are confirmed by targeting differentially enriched pathways in PN versus MES GBM that results in inhibition of distinct GBM subtypes. Correlative expressions of the components of this circuit are prognostic relevant for clinical GBM. Our findings provide insights for understanding GBM pathogenesis and for improving treatment of GBM.

Original languageEnglish (US)
Article number12885
JournalNature communications
Volume7
DOIs
StatePublished - Oct 4 2016

Fingerprint

phenotype
Glioblastoma
regulators
Phenotype
Networks (circuits)
Calcium-Calmodulin-Dependent Protein Kinase Type 2
pathogenesis
Wnt Signaling Pathway
Recurrence

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Cite this

Huang, Tianzhi ; Alvarez, Angel A. ; Pangeni, Rajendra P. ; Horbinski, Craig M. ; Lu, Songjian ; Kim, Sung Hak ; James, C. David ; Raizer, Jeffery J. ; Kessler, John A. ; Brenann, Cameron W. ; Sulman, Erik P. ; Finocchiaro, Gaetano ; Tan, Ming ; Nishikawa, Ryo ; Lu, Xinghua ; Nakano, Ichiro ; Hu, Bo ; Cheng, Shi Yuan. / A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways. In: Nature communications. 2016 ; Vol. 7.
@article{9651f621fe4047618796b5e42a00408c,
title = "A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways",
abstract = "Molecularly defined subclassification is associated with phenotypic malignancy of glioblastoma (GBM). However, current understanding of the molecular basis of subclass conversion that is often involved in GBM recurrence remain rudimentary at best. Here we report that canonical Wnt signalling that is active in proneural (PN) but inactive in mesenchymal (MES) GBM, along with miR-125b and miR-20b that are expressed at high levels in PN compared with MES GBM, comprise a regulatory circuit involving TCF4-miR-125b/miR-20b-FZD6. FZD6 acts as a negative regulator of this circuit by activating CaMKII-TAK1-NLK signalling, which, in turn, attenuates Wnt pathway activity while promoting STAT3 and NF-κ B signalling that are important regulators of the MES-associated phenotype. These findings are confirmed by targeting differentially enriched pathways in PN versus MES GBM that results in inhibition of distinct GBM subtypes. Correlative expressions of the components of this circuit are prognostic relevant for clinical GBM. Our findings provide insights for understanding GBM pathogenesis and for improving treatment of GBM.",
author = "Tianzhi Huang and Alvarez, {Angel A.} and Pangeni, {Rajendra P.} and Horbinski, {Craig M.} and Songjian Lu and Kim, {Sung Hak} and James, {C. David} and Raizer, {Jeffery J.} and Kessler, {John A.} and Brenann, {Cameron W.} and Sulman, {Erik P.} and Gaetano Finocchiaro and Ming Tan and Ryo Nishikawa and Xinghua Lu and Ichiro Nakano and Bo Hu and Cheng, {Shi Yuan}",
year = "2016",
month = "10",
day = "4",
doi = "10.1038/ncomms12885",
language = "English (US)",
volume = "7",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",

}

A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways. / Huang, Tianzhi; Alvarez, Angel A.; Pangeni, Rajendra P.; Horbinski, Craig M.; Lu, Songjian; Kim, Sung Hak; James, C. David; Raizer, Jeffery J.; Kessler, John A.; Brenann, Cameron W.; Sulman, Erik P.; Finocchiaro, Gaetano; Tan, Ming; Nishikawa, Ryo; Lu, Xinghua; Nakano, Ichiro; Hu, Bo; Cheng, Shi Yuan.

In: Nature communications, Vol. 7, 12885, 04.10.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways

AU - Huang, Tianzhi

AU - Alvarez, Angel A.

AU - Pangeni, Rajendra P.

AU - Horbinski, Craig M.

AU - Lu, Songjian

AU - Kim, Sung Hak

AU - James, C. David

AU - Raizer, Jeffery J.

AU - Kessler, John A.

AU - Brenann, Cameron W.

AU - Sulman, Erik P.

AU - Finocchiaro, Gaetano

AU - Tan, Ming

AU - Nishikawa, Ryo

AU - Lu, Xinghua

AU - Nakano, Ichiro

AU - Hu, Bo

AU - Cheng, Shi Yuan

PY - 2016/10/4

Y1 - 2016/10/4

N2 - Molecularly defined subclassification is associated with phenotypic malignancy of glioblastoma (GBM). However, current understanding of the molecular basis of subclass conversion that is often involved in GBM recurrence remain rudimentary at best. Here we report that canonical Wnt signalling that is active in proneural (PN) but inactive in mesenchymal (MES) GBM, along with miR-125b and miR-20b that are expressed at high levels in PN compared with MES GBM, comprise a regulatory circuit involving TCF4-miR-125b/miR-20b-FZD6. FZD6 acts as a negative regulator of this circuit by activating CaMKII-TAK1-NLK signalling, which, in turn, attenuates Wnt pathway activity while promoting STAT3 and NF-κ B signalling that are important regulators of the MES-associated phenotype. These findings are confirmed by targeting differentially enriched pathways in PN versus MES GBM that results in inhibition of distinct GBM subtypes. Correlative expressions of the components of this circuit are prognostic relevant for clinical GBM. Our findings provide insights for understanding GBM pathogenesis and for improving treatment of GBM.

AB - Molecularly defined subclassification is associated with phenotypic malignancy of glioblastoma (GBM). However, current understanding of the molecular basis of subclass conversion that is often involved in GBM recurrence remain rudimentary at best. Here we report that canonical Wnt signalling that is active in proneural (PN) but inactive in mesenchymal (MES) GBM, along with miR-125b and miR-20b that are expressed at high levels in PN compared with MES GBM, comprise a regulatory circuit involving TCF4-miR-125b/miR-20b-FZD6. FZD6 acts as a negative regulator of this circuit by activating CaMKII-TAK1-NLK signalling, which, in turn, attenuates Wnt pathway activity while promoting STAT3 and NF-κ B signalling that are important regulators of the MES-associated phenotype. These findings are confirmed by targeting differentially enriched pathways in PN versus MES GBM that results in inhibition of distinct GBM subtypes. Correlative expressions of the components of this circuit are prognostic relevant for clinical GBM. Our findings provide insights for understanding GBM pathogenesis and for improving treatment of GBM.

UR - http://www.scopus.com/inward/record.url?scp=84990852931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990852931&partnerID=8YFLogxK

U2 - 10.1038/ncomms12885

DO - 10.1038/ncomms12885

M3 - Article

C2 - 27698350

AN - SCOPUS:84990852931

VL - 7

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

M1 - 12885

ER -